Central Venous Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Central Venous Catheters Pipeline Market Report Overview

A central venous catheter is a long, thin, flexible tube used to administer medicines, fluids, nutrients, or blood products and to monitor haemodynamic status of the patients in surgical and critical care settings over a long period of time, usually several weeks or more. Central venous catheters come in different sizes. Antimicrobial, non-antimicrobial, and peripherally inserted central venous catheters are included under this category.

The central venous catheters pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Categories ·       PICC (Peripherally Inserted Central Catheter) Lines

·       Antimicrobial Central Venous Catheters

Key Territories ·       United States

·       Europe

·       China

·       India

·       Saudi Arabia

Key Regulatory Paths ·       510(k)

·       CE

·       ICAC

·       NMPA

Leading Companies ·       Acatechol Inc

·       Air Force Research Laboratory

·       Alshifa Medical Syringes Manufacturing Co Ltd

·       AngioDynamics Inc

·       Ash Access Technology Inc

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Central Venous Catheters Pipeline Market Segmentation by Categories

The key categories in the central venous catheters pipeline market are PICC (peripherally inserted central catheter) lines and antimicrobial central venous catheters. As of October 2024, PICC (peripherally inserted central catheter) lines had the highest number of pipeline products.

Central Venous Catheters Pipeline Market Analysis by Categories, 2024 (%)

Central Venous Catheters Pipeline Market Analysis by Categories, 2024 (%)

Buy the Full Report for More Category Insights into the Central Venous Catheters Pipeline Market

Download a Free Report Sample

Central Venous Catheters Pipeline Market Segmentation by Territories

A few of the key territories associated with the central venous catheters pipeline market are the United States, Europe, China, India, and Saudi Arabia. As of October 2024, the US had the highest number of central venous catheters pipeline products.

Central Venous Catheters Pipeline Market Analysis by Territories, 2024 (%)

Central Venous Catheters Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Central Venous Catheters Pipeline Market

Download a Free Report Sample

Central Venous Catheters Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the central venous catheters pipeline products market are 510(k), CE, ICAC, and NMPA. As of October 2024, 510(k) was the most followed pathway for pipeline products in the central venous catheters market.

Central Venous Catheters Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Central Venous Catheters Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Central Venous Catheters Pipeline Market

Download a Free Report Sample

Central Venous Catheters Pipeline Market – Competitive Landscape

A few of the key companies associated with the central venous catheters pipeline market are Acatechol Inc, Air Force Research Laboratory, Alshifa Medical Syringes Manufacturing Co Ltd, AngioDynamics Inc, and Ash Access Technology Inc among others.

Air Force Research Laboratory: Air Force Research Laboratory (AFRL) is a scientific research organization that leads the development, and delivery of warfighting technologies for air, space, and cyberspace forces. AFRL is headquartered in Dayton, Ohio, the US.

AngioDynamics Inc: AngioDynamics Inc (AngioDynamics) designs, manufactures and markets minimal invasive and image-guided therapeutics and diagnostic devices. Its product portfolio encompasses vascular products, radiofrequency ablation and NanoKnife systems, vascular access products, angiographic products and accessories, products for dialysis, angioplasty, drainage, thrombolysis and embolization, besides venous products and renal therapy products. The company’s products find application in interventional radiology, interventional cardiology, and minimally-invasive diagnosis and treatment of cancer and peripheral vascular disease

Central Venous Catheters Pipeline Market Analysis by Companies

Central Venous Catheters Pipeline Market Analysis by CompaniesBuy the Full Report for More Company Insights into the Central Venous Catheters Pipeline Market
Download a Free Report Sample

Segments Covered in the Report

Central Venous Catheters Pipeline Market Category Outlook (2024)

  • PICC (Peripherally Inserted Central Catheter) Lines
  • Antimicrobial Central Venous Catheters

Central Venous Catheters Pipeline Market Territories Outlook (2024)

  • United States
  • Europe
  • China
  • India
  • Saudi Arabia

Central Venous Catheters Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • CE
  • ICAC
  • NMPA

Scope

The report provides:

  • Extensive coverage of the central venous catheters under development.
  • The report reviews details of major pipeline products which include, product description, licensing and collaboration details, and other developmental activities.
  • The report reviews the major players involved in the development of central venous catheters and lists all their pipeline projects.
  • The coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of central venous catheters under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Acatechol Inc
Air Force Research Laboratory
Alshifa Medical Syringes Manufacturing Co Ltd
AngioDynamics Inc
Ash Access Technology Inc
Bactiguard Holding AB
Charite University Hospital of Berlin
CR Bard Inc
DAK Scientific Inc
Duke University
FreeFlow Medical Devices LLC
Globe Medical Tech Inc (Inactive)
Hospital for Special Surgery
Lipocoat BV
LiquiGlide Inc
Marvao Medical Devices Ltd
NHC LLC
Piccolo Medical Inc
Protectus Medical Devices, Inc.
S3V Vascular Technologies
Sharklet Technologies Inc
Silver Bullet Therapeutics, Inc.
Tel Aviv University
Truecath Inc
University of Illinois at Chicago
University of Texas Health Science Center at Houston
University of Washington
Velano Vascular East
Vindica Therapeutics, Inc

Table of Contents

|1 Table of Contents

|1.1 List of Tables

|1.2 List of Figures

2 Introduction

2.1 Central Venous Catheters Overview

3 Products under Development

3.1 Central Venous Catheters – Pipeline Products by Stage of Development

3.2 Central Venous Catheters – Pipeline Products by Segment

3.3 Central Venous Catheters – Pipeline Products by Territory

3.4 Central Venous Catheters – Pipeline Products by Regulatory Path

3.5 Central Venous Catheters – Pipeline Products by Estimated Approval Date

4 Central Venous Catheters – Pipeline Products under Development by Companies

4.1 Central Venous Catheters Companies – Pipeline Products by Stage of Development

4.2 Central Venous Catheters – Pipeline Products by Stage of Development

5 Central Venous Catheters Companies and Product Overview

5.1 Acatechol Inc Company Overview

5.1.1 Acatechol Inc Pipeline Products & Ongoing Clinical Trials Overview

5.2 Air Force Research Laboratory Company Overview

5.2.1 Air Force Research Laboratory Pipeline Products & Ongoing Clinical Trials Overview

5.3 Alshifa Medical Syringes Manufacturing Co Ltd Company Overview

5.3.1 Alshifa Medical Syringes Manufacturing Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.4 AngioDynamics Inc Company Overview

5.4.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.5 Ash Access Technology Inc Company Overview

5.5.1 Ash Access Technology Inc Pipeline Products & Ongoing Clinical Trials Overview

5.6 Bactiguard Holding AB Company Overview

5.6.1 Bactiguard Holding AB Pipeline Products & Ongoing Clinical Trials Overview

5.7 Charite University Hospital of Berlin Company Overview

5.7.1 Charite University Hospital of Berlin Pipeline Products & Ongoing Clinical Trials Overview

5.8 CR Bard Inc Company Overview

5.8.1 CR Bard Inc Pipeline Products & Ongoing Clinical Trials Overview

5.9 DAK Scientific Inc Company Overview

5.9.1 DAK Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview

5.10 Duke University Company Overview

5.10.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview

5.11 FreeFlow Medical Devices LLC Company Overview

5.11.1 FreeFlow Medical Devices LLC Pipeline Products & Ongoing Clinical Trials Overview

5.12 Globe Medical Tech Inc (Inactive) Company Overview

5.12.1 Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.13 Hospital for Special Surgery Company Overview

5.13.1 Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview

5.14 Lipocoat BV Company Overview

5.14.1 Lipocoat BV Pipeline Products & Ongoing Clinical Trials Overview

5.15 LiquiGlide Inc Company Overview

5.15.1 LiquiGlide Inc Pipeline Products & Ongoing Clinical Trials Overview

5.16 Marvao Medical Devices Ltd Company Overview

5.16.1 Marvao Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.17 NHC LLC Company Overview

5.17.1 NHC LLC Pipeline Products & Ongoing Clinical Trials Overview

5.18 Piccolo Medical Inc Company Overview

5.18.1 Piccolo Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.19 Protectus Medical Devices, Inc. Company Overview

5.19.1 Protectus Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.20 S3V Vascular Technologies Company Overview

5.20.1 S3V Vascular Technologies Pipeline Products & Ongoing Clinical Trials Overview

5.21 Sharklet Technologies Inc Company Overview

5.21.1 Sharklet Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

5.22 Silver Bullet Therapeutics, Inc. Company Overview

5.22.1 Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.23 Tel Aviv University Company Overview

5.23.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview

5.24 Truecath Inc Company Overview

5.24.1 Truecath Inc Pipeline Products & Ongoing Clinical Trials Overview

5.25 University of Illinois at Chicago Company Overview

5.25.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview

5.26 University of Texas Health Science Center at Houston Company Overview

5.26.1 University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview

5.27 University of Washington Company Overview

5.27.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview

5.28 Velano Vascular East Company Overview

5.28.1 Velano Vascular East Pipeline Products & Ongoing Clinical Trials Overview

5.29 Vindica Therapeutics, Inc Company Overview

5.29.1 Vindica Therapeutics, Inc Pipeline Products & Ongoing Clinical Trials Overview

6 Central Venous Catheters- Recent Developments

6.1 Oct 03, 2024: ICU Medical Appoints New President

6.2 Oct 01, 2024: Correcting and Replacing Access Vascular Highlights New Midline Catheter Data at AVA 2024

6.3 Sep 24, 2024: B. Braun Medical Receives FDA Clearance for Introcan Safety 2 Deep Access IV Catheter

6.4 Aug 13, 2024: Becton Dickinson Receives Additional 510(k) Clearance For PowerGlide Pro Midline Catheter

6.5 Aug 05, 2024: B. Braun Medical Receives Additional 510(K) Clearance For Introcan Safety 2 IV Catheter

6.6 Jul 24, 2024: Access Vascular Prepares Catheter Location Technology for FDA Submission

6.7 Jul 24, 2024: ICU Medical Announces Time of Second Quarter 2024 Earnings Conference Call

6.8 Jul 17, 2024: ICU Medical Plans to Close Oakdale Facility, Lay Off 83 Employees

6.9 May 21, 2024: Access Vascular Announces New Bacterial Adhesion Data at INS 2024

6.10 Apr 23, 2024: ICU Medical Announces Time of First Quarter 2024 Earnings Conference Call

6.11 Feb 08, 2024: Teleflex Announces Fourth Quarter 2023 Earnings Conference Call Information

6.12 Jan 04, 2024: Piccolo Medical Awarded a Commercialization Readiness Pilot (CRP) Program grant from the National Institute of Health

6.13 Dec 19, 2023: Argon Medical Devices Receives 510(K) Clearance For L-Cath Midline Catheter

6.14 Dec 15, 2023: L&Z Receives 510(K) Clearance For CATHTONG III Tapered PICC Catheter

6.15 Dec 14, 2023: Argon Medical Devices Receives FDA 510(k) Clearance for L-Cath Single and Dual Lumen Catheter

6.16 Dec 05, 2023: Teleflex Awarded Peripheral Access Agreement with Premier

6.17 Dec 01, 2023: Retractable Technologies Not Impacted by FDA Safety Communication

6.18 Nov 14, 2023: BD to Present at the 6th Annual Evercore ISI HealthCONx Conference

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer

Table

Central Venous Catheters – Pipeline Products by Stage of Development

Central Venous Catheters – Pipeline Products by Segment

Central Venous Catheters – Pipeline Products by Territory

Central Venous Catheters – Pipeline Products by Regulatory Path

Central Venous Catheters – Pipeline Products by Estimated Approval Date

Central Venous Catheters Companies – Pipeline Products by Stage of Development

Central Venous Catheters – Pipeline Products by Stage of Development

Acatechol Inc Pipeline Products & Ongoing Clinical Trials Overview

Antimicrobial Central Venous Catheter – Product Status

Antimicrobial Central Venous Catheter – Product Description

Air Force Research Laboratory Pipeline Products & Ongoing Clinical Trials Overview

Pulsing Frontline Trace Catheter – Product Status

Pulsing Frontline Trace Catheter – Product Description

Alshifa Medical Syringes Manufacturing Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

ALSHIFA IV Catheter – Product Status

ALSHIFA IV Catheter – Product Description

AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview

BioFlo PICC Line Extension – Product Status

BioFlo PICC Line Extension – Product Description

Next Generation BioFlo PICC – Product Status

Next Generation BioFlo PICC – Product Description

Ash Access Technology Inc Pipeline Products & Ongoing Clinical Trials Overview

BaxCath Impregnation System – Product Status

BaxCath Impregnation System – Product Description

Bactiguard Holding AB Pipeline Products & Ongoing Clinical Trials Overview

Transvascular Injection Catheter – Product Status

Transvascular Injection Catheter – Product Description

Charite University Hospital of Berlin Pipeline Products & Ongoing Clinical Trials Overview

Central Venous Permanent Catheter – Product Status

Central Venous Permanent Catheter – Product Description

CR Bard Inc Pipeline Products & Ongoing Clinical Trials Overview

Anti-Thrombotic PICC – Product Status

Anti-Thrombotic PICC – Product Description

Antimicrobial PICC – Product Status

Antimicrobial PICC – Product Description

COVERT PowerPICC – Product Status

COVERT PowerPICC – Product Description

DAK Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview

PICC Line – Product Status

PICC Line – Product Description

Duke University Pipeline Products & Ongoing Clinical Trials Overview

Central Venous Catheter Insertion Device – Product Status

Central Venous Catheter Insertion Device – Product Description

Intravenous Catheter – Product Status

Intravenous Catheter – Product Description

FreeFlow Medical Devices LLC Pipeline Products & Ongoing Clinical Trials Overview

TLP-Coated PICC Catheter – Product Status

TLP-Coated PICC Catheter – Product Description

Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Safety IV Catheter – Product Status

Safety IV Catheter – Product Description

Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview

IV Catheter – Product Status

IV Catheter – Product Description

Lipocoat BV Pipeline Products & Ongoing Clinical Trials Overview

Coated CVC Catheter – Product Status

Coated CVC Catheter – Product Description

LiquiGlide Inc Pipeline Products & Ongoing Clinical Trials Overview

LIS-Coated PICC – Product Status

LIS-Coated PICC – Product Description

Marvao Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview

NexSite 8Fr Single Lumen Central Venous Catheter – Product Status

NexSite 8Fr Single Lumen Central Venous Catheter – Product Description

NHC LLC Pipeline Products & Ongoing Clinical Trials Overview

Otricath – Product Status

Otricath – Product Description

Piccolo Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

Gen 2 Smart PICC System – Product Status

Gen 2 Smart PICC System – Product Description

Protectus Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Safety IV Catheter – Product Status

Safety IV Catheter – Product Description

S3V Vascular Technologies Pipeline Products & Ongoing Clinical Trials Overview

3V AGILE – Product Status

3V AGILE – Product Description

Sharklet Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

Sharklet Central Venous Catheter – Product Status

Sharklet Central Venous Catheter – Product Description

Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Cathanic Venous Catheter – Product Status

Cathanic Venous Catheter – Product Description

Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview

Short Peripheral Infusion Catheter – Product Status

Short Peripheral Infusion Catheter – Product Description

Truecath Inc Pipeline Products & Ongoing Clinical Trials Overview

TrueCath Auto-catheter – Product Status

TrueCath Auto-catheter – Product Description

University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview

Extendable Intravenous Catheter – Product Status

Extendable Intravenous Catheter – Product Description

University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview

Automated Catheter Insertion System – Product Status

Automated Catheter Insertion System – Product Description

University of Washington Pipeline Products & Ongoing Clinical Trials Overview

Advanced Medical Catheter – Product Status

Advanced Medical Catheter – Product Description

Velano Vascular East Pipeline Products & Ongoing Clinical Trials Overview

China Midline Catheter – Product Status

China Midline Catheter – Product Description

Next Gen Central Catheter – Product Status

Next Gen Central Catheter – Product Description

Vindica Therapeutics, Inc Pipeline Products & Ongoing Clinical Trials Overview

Anti-Thrombotic And Anti-Infective Central Venous Catheter – Product Status

Anti-Thrombotic And Anti-Infective Central Venous Catheter – Product Description

Glossary

Figures

Central Venous Catheters – Pipeline Products by Stage of Development

Central Venous Catheters – Pipeline Products by Segment

Central Venous Catheters – Pipeline Products by Territory

Central Venous Catheters – Pipeline Products by Regulatory Path

Central Venous Catheters – Pipeline Products by Estimated Approval Date

Frequently asked questions

Central Venous Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Central Venous Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Central Venous Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Central Venous Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.